The End of the “Silent Decline”: How AI and Wearables are Redefining Dementia Early Detection The window for treating dementia has traditionally …
Biomarker
-
-
Beyond the Fog: How the Long COVID Immune Signature is Revolutionizing Post-Viral Diagnostics For millions of people worldwide, the end of an …
-
For decades, the fight against colorectal cancer has focused primarily on the tumor cells themselves. However, the real battle is often won …
-
The End of Reactive Medicine: AI’s Shift Toward ‘Tipping Point’ Forecasting For decades, the gold standard of medicine has been early detection—finding …
-
For patients facing high-grade neuroendocrine tumors (NETs), the medical landscape has long been defined by a stark reality: limited options and a …
-
A significant leap forward in personalized cancer prevention has been achieved by researchers at MD Anderson Cancer Center: a blood-based biomarker capable …
-
The Silent Epidemic: How Sleep-Based Brain Age Testing Will Revolutionize Dementia Detection Nearly 55 million people globally live with dementia, and that …
-
The Dawn of Predictive Dementia Care: How Brain Metabolism & AI Blood Tests Will Reshape Alzheimer’s Prevention by 2026 Nearly 6 million …
-
Liquid Biopsies Poised to Revolutionize Throat Cancer Treatment – A New Era of Personalized Oncology Every year, approximately 22,000 individuals in the …
-
A significant breakthrough in understanding IgA nephropathy – a leading cause of kidney disease – has emerged from research at Fujita Health …